MedTrace Logo

Individual Education on Rational Drug Use in Primary Healthcare for Patients on Long-Term Medication

NCT06700642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 365

Last updated 2024-11-22

No results posted yet for this study

Summary

Irrational medication use is a common problem in Turkiye and worldwide. Educational interventions are essential to promote rational drug use. This study was conducted to evaluate the effect of individual education on rational drug use given to individuals aged 45-74 years with at least one continuously used medication who applied to a primary health care institution on their rational drug use level. The hypothesis of the study was that individual training on rational drug use given to individuals using medication continuously is effective in increasing rational drug use.

Conditions

  • Medication Adherence
  • Patient Compliance
  • Drug Utilization Review

Interventions

OTHER

Educational intervention

In this study, 3 intervention tools were developed by the researchers. The first of these, 'Rational Drug Use Trainer Guide', was used for trainer training and standardisation of the education given to patients. The sample rational drug use presentations prepared by the Ministry of Health, Turkiye Medicines and Medical Devices Agency, Department of Rational Drug Use were combined in terms of content, enriched with information obtained from the literature and developed for the use of family physicians working in primary health care institutions in their clinical practices. 'Rational Drug Use Individual Education Presentation' was prepared by the researchers in line with the 'Rational Drug Use Trainer Guide'. It has been prepared in a format suitable for individual education presentation with the most concise and understandable content suitable for use during primary healthcare service delivery. 'Rational Drug Use Patient Brochure' was prepared by the researchers in a similar content.

Sponsors & Collaborators

  • Gülşah Onur

    lead OTHER

Principal Investigators

  • Gülşah Onur, Research Assistant Dr. · Hacettepe University Faculty of Medicine, Department of Family Medicine

  • Duygu Ayhan Başer, Assoc. Prof. · Hacettepe University Faculty of Medicine, Department of Family Medicine

  • Bahar (Güçiz) Doğan, Prof. · Hacettepe University Institute of Public Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-01-12
Completion
2024-04-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06700642 on ClinicalTrials.gov